Question · asked by 1 review
CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) vs HIGH DOSE (> 800 mg/day ‐ all medium term): Clinical response: no clinically significant response in mental state
- Population
- schizophrenia
- Intervention
- CHLORPROMAZINE LOW DOSE (≤ 400 mg/day)
- Comparison
- HIGH DOSE (> 800 mg/day ‐ all medium term)
- Outcome
- Clinical response: no clinically significant response in mental state
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) vs HIGH DOSE (> 800 mg/day ‐ all medium term) Mental state: no clinically important change in mental state · patients with people with schizophrenia Chlorpromazine dose for people with schizophrenia (2017) · Cochrane Headline outcomes only | no estimate extracted | 0 studies · 0 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Chlorpromazine dose for people with schizophrenia 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.